Erez Raphael - 16 Aug 2024 Form 4 Insider Report for DarioHealth Corp. (DRIO)

Role: Chief Executive Officer, Director
Signature: /s/ Erez Raphael
Issuer symbol: DRIO
Transactions as of: 16 Aug 2024
Net transactions value: +$8,980
Form type: 4
Filing time: 20 Aug 2024, 16:01:15 UTC
Previous filing: 08 Mar 2024
Next filing: 23 Aug 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DRIO	Common Stock	Purchase	$1,780	+2,000	+0.1%	$0.8900	1,914,059	16 Aug 2024	Direct
transaction	DRIO	Common Stock	Purchase	$2,700	+3,000	+0.16%	$0.9000	1,917,059	16 Aug 2024	Direct
transaction	DRIO	Common Stock	Purchase	$4,500	+5,000	+0.26%	$0.9000	1,922,059	19 Aug 2024	Direct
holding	DRIO	Common Stock						37,876	16 Aug 2024	By Dicilyon Consulting and Investment Ltd.	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein.

Content

The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein.